Follow
Steven Moss
Steven Moss
Verified email at brown.edu
Title
Cited by
Cited by
Year
Gastroenteropancreatic neuroendocrine tumours
IM Modlin, K Oberg, DC Chung, RT Jensen, WW De Herder, RV Thakker, ...
The lancet oncology 9 (1), 61-72, 2008
20242008
ACG clinical guideline: treatment of Helicobacter pylori infection
WD Chey, GI Leontiadis, CW Howden, SF Moss
Official journal of the American College of Gastroenterology| ACG 112 (2 …, 2017
16622017
Induction of gastric epithelial apoptosis by Helicobacter pylori.
SF Moss, J Calam, B Agarwal, S Wang, PR Holt
Gut 38 (4), 498-501, 1996
6091996
Chromogranin A—biological function and clinical utility in neuro endocrine tumor disease
IM Modlin, BI Gustafsson, SF Moss, M Pavel, AV Tsolakis, M Kidd
Annals of surgical oncology 17, 2427-2443, 2010
5032010
Helicobacter pylori cagA + Strains and Dissociation of Gastric Epithelial Cell Proliferation From Apoptosis
RM Peek Jr, SF Moss, S Wang, PR Holt, KT Tham, MJ Blaser, ...
Journal of the National Cancer Institute 89 (12), 863-868, 1997
4831997
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set
DS Klimstra, IR Modlin, NV Adsay, R Chetty, V Deshpande, M Gönen, ...
The American journal of surgical pathology 34 (3), 300-313, 2010
4492010
Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas
M Krajewska, SF Moss, S Krajewski, KI Song, PR Holt, JC Reed
Cancer Research 56 (10), 2422-2427, 1996
4331996
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses
DA Israel, N Salama, CN Arnold, SF Moss, T Ando, HP Wirth, KT Tham, ...
The Journal of clinical investigation 107 (5), 611-620, 2001
4222001
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
N Arber, H Hibshoosh, SF Moss, T Sutter, Y Zhang, M Begg, S Wang, ...
Gastroenterology 110 (3), 669-674, 1996
4211996
Mechanisms of disease: inflammation and the origins of cancer
SF Moss, MJ Blaser
Nature clinical practice Oncology 2 (2), 90-97, 2005
4142005
Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease
SF Moss, J Calam, S Legon, AE Bishop, JM Polak
The Lancet 340 (8825), 930-932, 1992
3891992
Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells
B Agarwal, S Bhendwal, B Halmos, SF Moss, WG Ramey, PR Holt
Clinical Cancer Research 5 (8), 2223-2229, 1999
3501999
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors
IM Modlin, SF Moss, DC Chung, RT Jensen, E Snyderwine
JNCI: Journal of the National Cancer Institute 100 (18), 1282-1289, 2008
3042008
Consensus on biomarkers for neuroendocrine tumour disease
K Oberg, IM Modlin, W De Herder, M Pavel, D Klimstra, A Frilling, DC Metz, ...
The Lancet Oncology 16 (9), e435-e446, 2015
2992015
The clinical evidence linking Helicobacter pylori to gastric cancer
SF Moss
Cellular and molecular gastroenterology and hepatology 3 (2), 183-191, 2017
2922017
Helicobacter pylori virulence factors in gastric carcinogenesis
S Wen, SF Moss
Cancer letters 282 (1), 1-8, 2009
2912009
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma
SS Kim, VE Ruiz, JD Carroll, SF Moss
Cancer letters 305 (2), 228-238, 2011
2712011
Diagnosis and management of non-erosive reflux disease–the Vevey NERD Consensus Group
IM Modlin, RH Hunt, P Malfertheiner, P Moayyedi, EM Quigley, GNJ Tytgat, ...
Digestion 80 (2), 74-88, 2009
2662009
Reconciliation of recent Helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics
CA Fallone, SF Moss, P Malfertheiner
Gastroenterology 157 (1), 44-53, 2019
2422019
Cytokine gene expression in Helicobacter pylori associated antral gastritis.
SF Moss, S Legon, J Davies, J Calam
Gut 35 (11), 1567-1570, 1994
2411994
The system can't perform the operation now. Try again later.
Articles 1–20